Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1985 2
1986 6
1987 7
1988 15
1989 11
1990 37
1991 24
1992 56
1993 99
1994 116
1995 113
1996 115
1997 94
1998 103
1999 91
2000 82
2001 76
2002 79
2003 83
2004 101
2005 90
2006 81
2007 88
2008 96
2009 107
2010 131
2011 124
2012 140
2013 142
2014 139
2015 147
2016 159
2017 191
2018 165
2019 179
2020 223
2021 212
2022 195
2023 163
2024 183
2025 201
2026 113

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,167 results

Results by year

Filters applied: . Clear all
Page 1
[Ketorolac].
Simón M, Quetglas EG, Honorato J. Simón M, et al. Rev Med Univ Navarra. 1995 Jan-Mar;39(1):41-5. Rev Med Univ Navarra. 1995. PMID: 14735716 Review. Spanish. No abstract available.
Ketorolac 0.45% ophthalmic solution.
McCormack PL. McCormack PL. Drugs Aging. 2011 Jul 1;28(7):583-9. doi: 10.2165/11207450-000000000-00000. Drugs Aging. 2011. PMID: 21721602 Review.
Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation following cataract surgery. In animal studies, the ocular relative bioavailability of single-dose topical ketorolac 0.45% ophthalmic solution …
Ketorolac 0.45% ophthalmic solution is a topical NSAID indicated in the US for the treatment of ocular pain and inflammation followin …
Ketorolac for postoperative pain in children.
McNicol ED, Rowe E, Cooper TE. McNicol ED, et al. Cochrane Database Syst Rev. 2018 Jul 7;7(7):CD012294. doi: 10.1002/14651858.CD012294.pub2. Cochrane Database Syst Rev. 2018. PMID: 29981164 Free PMC article.
Only one study reported data for opioid consumption when comparing ketorolac with an opioid. There were no clear differences between the ketorolac and opioid group at any time point. ...Although the majority of serious adverse events reported in those receiving k …
Only one study reported data for opioid consumption when comparing ketorolac with an opioid. There were no clear differences between …
Injectable Nonsteroidal Anti-Inflammatory Drugs in Sport.
Matava MJ. Matava MJ. Clin J Sport Med. 2018 Sep;28(5):443-450. doi: 10.1097/JSM.0000000000000602. Clin J Sport Med. 2018. PMID: 29771750 Review.
Complications related to NSAID use involve primarily the gastrointestinal, renal, and cardiovascular systems through this COX pathway inhibition. Ketorolac is the only NSAID currently available in an injectable form. Despite its analgesic efficacy comparable with opioid me …
Complications related to NSAID use involve primarily the gastrointestinal, renal, and cardiovascular systems through this COX pathway inhibi …
Ketorolac Injections for Musculoskeletal Conditions: A Narrative Review.
Kiel J, Applewhite AI, Bertasi TGO, Bertasi RAO, Seemann LL, Costa LMC, Helmi H, Pujalte GGA. Kiel J, et al. Clin Med Res. 2024 Mar;22(1):19-27. doi: 10.3121/cmr.2024.1847. Clin Med Res. 2024. PMID: 38609144 Free PMC article. Review.
A review of the current literature was conducted on the efficacy of ketorolac injection in musculoskeletal diseases. Several studies support the use and efficacy of ketorolac injection in subacromial bursitis, adhesive capsulitis, and hip and knee osteoarthritis. .. …
A review of the current literature was conducted on the efficacy of ketorolac injection in musculoskeletal diseases. Several studies …
Pediatric Tonsillectomy and Ketorolac.
Phillips-Reed LD, Austin PN, Rodriguez RE. Phillips-Reed LD, et al. J Perianesth Nurs. 2016 Dec;31(6):485-494. doi: 10.1016/j.jopan.2015.02.005. Epub 2016 May 5. J Perianesth Nurs. 2016. PMID: 27931700 Review.
Subgroup analysis often allowed assessment of the effects of ketorolac administration. FINDING: There was no consensus on the increased risk of bleeding when nonsteriodal anti-inflammatory drugs such as ketorolac are given to pediatric patients undergoing tonsillect …
Subgroup analysis often allowed assessment of the effects of ketorolac administration. FINDING: There was no consensus on the increas …
Ketorolac use in the emergency department in children: a systematic review and meta-analysis.
Tessitore A, Zupin L, Celsi F, Capaci V, Amaddeo A, Barbi E, Cozzi G. Tessitore A, et al. Eur J Pediatr. 2025 Apr 14;184(5):296. doi: 10.1007/s00431-025-06128-2. Eur J Pediatr. 2025. PMID: 40229463 Free PMC article.
A meta-analysis was subsequently conducted to compare efficacy of ketorolac with other analgesic medications. Eight RCTs have investigated the efficacy of ketorolac for acute pain in children in the ED, reflecting limited pediatric evidence. Ketorolac showed …
A meta-analysis was subsequently conducted to compare efficacy of ketorolac with other analgesic medications. Eight RCTs have investi …
Evidence-based safety profile of oral ketorolac in adults: Systematic review and meta-analysis.
Esparza-Villalpando V, Ortiz-Barroso G, Masuoka-Ito D. Esparza-Villalpando V, et al. Pharmacol Res Perspect. 2024 Dec;12(6):e70033. doi: 10.1002/prp2.70033. Pharmacol Res Perspect. 2024. PMID: 39579063 Free PMC article.
The present study is a PRISMA-based systematic review and risk ratio (RR) meta-analysis of the adverse events reported in clinical trials that used oral ketorolac; the review includes 50 clinical trials. The RR for the comparison of a single intake of oral ketorolac …
The present study is a PRISMA-based systematic review and risk ratio (RR) meta-analysis of the adverse events reported in clinical trials th …
Ketorolac in the perioperative management of acute type A aortic dissection: a randomized double-blind placebo-controlled trial.
Lv ZK, Zhang HT, Cai XJ, Su WX, Zhu EJ, Chong H, Zhu XY, Kong YR, Tang YX, Li X, Luo YX, Luo HQ, Pan HD, Sun YH, Li K, Jin M, Li SC, Chen HY, Bi ZQ, Zhao YL, Xu ZJ, Cheng YQ, Xu WZ, Chen C, Zhao WW, Wang ZG, Lu LC, Pan J, Fan FD, Xue YX, Zhang BM, Ge M, Ye JX, Kong CY, Xie BD, Pan T, Wang DJ. Lv ZK, et al. BMC Med. 2025 Mar 28;23(1):188. doi: 10.1186/s12916-025-04021-1. BMC Med. 2025. PMID: 40156036 Free PMC article. Clinical Trial.
This study seeks to evaluate the safety and effectiveness of ketorolac in this patient group. METHODS: Patients were randomly assigned to receive either ketorolac or a placebo (0.9% saline). Treatment began at least 2 h prior to surgery (60 mg ketorolac or 2 …
This study seeks to evaluate the safety and effectiveness of ketorolac in this patient group. METHODS: Patients were randomly assigne …
Intranasal ketorolac: for short-term pain management.
Garnock-Jones KP. Garnock-Jones KP. Clin Drug Investig. 2012 Jun 1;32(6):361-71. doi: 10.2165/11209240-000000000-00000. Clin Drug Investig. 2012. PMID: 22574632 Review.
Intranasal ketorolac has recently become available. Intranasal ketorolac was effective in providing short-term relief from postoperative pain in four well designed, phase II or III trials. ...Moreover, a greater proportion of ketorolac recipients experienced …
Intranasal ketorolac has recently become available. Intranasal ketorolac was effective in providing short-term relief from pos …
4,167 results